These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. Gorse GJ; Otto EE; Powers DC; Chambers GW; Eickhoff CS; Newman FK J Infect Dis; 1996 Feb; 173(2):285-90. PubMed ID: 8568287 [TBL] [Abstract][Full Text] [Related]
6. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory. Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667 [TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193 [TBL] [Abstract][Full Text] [Related]
9. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine? Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584 [TBL] [Abstract][Full Text] [Related]
10. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [TBL] [Abstract][Full Text] [Related]
11. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration. Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074 [TBL] [Abstract][Full Text] [Related]
12. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. Clements ML; Murphy BR J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610 [TBL] [Abstract][Full Text] [Related]
13. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine. Zahradnik JM; Kasel JA; Martin RR; Six HR; Cate TR J Med Virol; 1983; 11(4):277-85. PubMed ID: 6875521 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145 [TBL] [Abstract][Full Text] [Related]
15. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645 [TBL] [Abstract][Full Text] [Related]
16. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Clements ML; Betts RF; Murphy BR Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042 [TBL] [Abstract][Full Text] [Related]
17. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines. Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535 [TBL] [Abstract][Full Text] [Related]
18. Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines. Gruber WC; Hinson HP; Holland KL; Thompson JM; Reed GW; Wright PF J Infect Dis; 1993 Nov; 168(5):1282-5. PubMed ID: 8228364 [TBL] [Abstract][Full Text] [Related]
19. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF J Med Virol; 1985 Dec; 17(4):325-35. PubMed ID: 4078559 [TBL] [Abstract][Full Text] [Related]
20. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. Khan AS; Polezhaev F; Vasiljeva R; Drinevsky V; Buffington J; Gary H; Sominina A; Keitel W; Regnery H; Lonskaya NL; Doroshenko E; Gavrilov A; Ivakhov I; Arden N; Schonberger LB; Couch R; Kendal A; Cox N J Infect Dis; 1996 Feb; 173(2):453-6. PubMed ID: 8568310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]